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Background
Hospital-acquired diagnoses (HAD) not only lengthen
inpatients’ recovery times but also incur significant addi-
tional costs of care. The focus of previous research has
been on ‘highly preventable’ indicator conditions and
the cost of individual episodes, rather than on the entire
spectrum of unintentional patient harm. As well, little
attention has been paid to the frequency of HADs and
resulting total costs.
Objective
The objective of this study was to estimate the incre-
mental cost, aggregated system costs, and length-of-stay
effects of hospital-acquired diagnoses in eight Alberta
(Canada) hospitals.
Methods
Routinely coded diagnosis data, combined with a Pre-
sent-on-Admission (POA) flag, were used to group
206,011 inpatient records into the 144 classes of the
Classification of Hospital Acquired Diagnoses (CHADx).
In Alberta’s larger hospitals, costs are measured using
sophisticated bottom-up, patient-level costing systems.
We employed a generalized linear model (GLM) with
a gamma distribution using a log link relationship
between the total cost of hospitalization and all 144
CHADx groups, after controlling for in-hospital death,
one-day hospitalization, and the mean of uncomplicated
cases in each CaseMix Group (CMG).
Results
Nearly a quarter of the sample (23.9%) had at least one
recorded hospital-acquired diagnosis. Across all cases,
any HAD was associated with increased costs of C
$10,866, more than double the mean cost of an uncom-
plicated admission, with a mean of 4.7 additional days
of stay. CHADx representing the highest per-episode
median incremental cost included multi-drug resistant
Staph aureus (CHADx 4.3, C$11,357), falls with frac-
tured neck of femur (CHADx 3.1, C$6,679), and pres-
sure ulcers (CHADx 8.1, C$6,512). Twenty-two CHADx
added > 2 days to the median for a similar but uncom-
plicated stay.
Taking the volume of cases into account, and using an
approximation of the mean incremental cost to capture
all system costs, urinary tract infection (CHADx 9.2)
was the most costly, adding C$19.3 million to system
costs. CHADx responsible for the greatest extension of
LOS (length of stay) across the system were similar to
those adding the greatest costs, with the notable addi-
tions of Clostridium difficile infection (CHADx 7.3,
+8,813 days) and septicaemia (CHADx 4.1, +6,284).
High-level grouping of CHADx showed hospital-
acquired infections to be the mostly costly type of com-
plication, adding C$49.6 million, although this finding is
s e n s i t i v et ot h ew a yi nw h i c hH A Dc o n d i t i o n sa r e
grouped.
Discussion
Few hospital-acquired diagnoses are preventable in every
case, but most have been shown to be amenable to a
reduction in their rates. POA flags on routine diagnosis
data considerably improve the ability to identify com-
promised patient care, although such data will remain
controversial without further efforts to improve medical
record documentation. Adding financial and length-of-
stay dimensions to discussions about hospital quality
improvement may strengthen efforts to reduce harm to
patients, as will timely access to local data.
* Correspondence: terri.jackson@ualberta.ca
1Division of Pulmonary Medicine, Faculty of Medicine and Dentistry,
University of Alberta, Edmonton, T6G 2C8, Canada
Full list of author information is available at the end of the article
Jackson et al. BMC Health Services Research 2011, 11(Suppl 1):A15
http://www.biomedcentral.com/1472-6963/11/S1/A15
© 2011 Jackson et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Acknowledgements
The authors wish to thank Alberta Health Services for access to de-identified
patient-level data. However, we note that this paper is not endorsed by
Alberta Health Services, nor does it represent official AHS policy.
This study was granted ethical approval by the Human Research Ethics
Board of the University of Alberta.
Author details
1Division of Pulmonary Medicine, Faculty of Medicine and Dentistry,
University of Alberta, Edmonton, T6G 2C8, Canada.
2Health Policy and
Management, School of Public Health, University of Alberta, Edmonton, T6G
2C8, Canada.
3Data Integration Measurement and Reporting, Strategy and
Performance, Alberta Health Services, Calgary, Canada.
4Provincial Operations,
Standards and Strategies, Health Information, Alberta Health Services,
Calgary, Canada.
Published: 19 October 2011
doi:10.1186/1472-6963-11-S1-A15
Cite this article as: Jackson et al.: Incremental costs of hospital-acquired
complications in Alberta, Canada. BMC Health Services Research 2011 11
(Suppl 1):A15.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jackson et al. BMC Health Services Research 2011, 11(Suppl 1):A15
http://www.biomedcentral.com/1472-6963/11/S1/A15
Page 2 of 2